http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MX-2008013546-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_291ed84f4388333ad126a75f01f210c9
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7028
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-337
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-337
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-704
filingDate 2007-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b5a74a731aaa5666ec81349d5ce6f63b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7e566aa91671af7b9faf5f8d2477fbe2
publicationDate 2009-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber MX-2008013546-A
titleOfInvention ANTICANCER TREATMENT WITH A COMBINATION OF TAXANS AND 13-DEOXIANTRACICLINES.
abstract A 1 3-deoxyanthracicline and a taxane can be administered to a patient simultaneously, separately, sequentially or consecutively to produce an anticancer therapeutic effect with reduced toxicity and side effect profile, compared to the administration of equieffective amounts of any of the compounds alone. . A composition or preparation of a 13-deoxyanthracicline and a taxane is also provided to produce a potent anti-cancer therapeutic effect.
priorityDate 2006-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID443832
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7083
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410442395
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449012232
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419492855
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419504230
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415967685
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID160128
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID148124
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID148241940
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419492617
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID83970
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID30323
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID443829
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID36314
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3440921
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419587275
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419520100
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415777894
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415967683

Total number of triples: 38.